Investigation of the longitudinal relaxation rate of blood after gadobenate dimeglumine administration: Sequence optimization, dynamic acquisition, and clinical impact for contrast-enhanced MR angiography of the carotid arteries

Investigative Radiology

Volumn 46, Issue 12, 2011, Pages 774-782

  Neira, Cristina ^a   Anzidei, Michele ^b   Napoli, Alessandro ^b   Kirchin, Miles A ^a   Marincola, Beatrice Cavallo ^b   Zaccagna, Fulvio ^b   Catalano, Carlo ^b   Passariello, Roberto ^b   Tedoldi, Fabio ^b  

^a Bracco Imaging SpA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

carotid arteries; contrast enhanced MR angiography; gadobenate dimeglumine; MR relaxometry; MultiHance

Indexed keywords

GADOBENATE DIMEGLUMINE;

ADULT; AGED; ARTICLE; BLOOD; BLOOD RELAXATION RATE; CAROTID ARTERY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PHANTOM; PRIORITY JOURNAL;

EID: 81855170192     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e318227c57c     Document Type: Article

References (41)

1. Lauffer RB, Parmelee DJ, Dunham SU, et al. Gadofosveset: albumin-targeted contrast agent for MR angiography. Radiology. 1998;207:529-538. (Pubitemid 28259074)
2. Caravan P, Cloutier NJ, Greenfield MT, et al. The interaction of gadofosveset with human serum albumin and its effect on proton relaxation rates. J Am Chem Soc. 2002;124:3152-3162. (Pubitemid 34249987)
3. Caravan P. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action. Acc Chem Res. 2009;42:851-862.
4. Parmelee DJ, Walovitch RC, Ouellet HS, et al. Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of gadofosveset, a blood pool agent for magnetic resonance imaging. Invest Radiol. 1997;32:741-747. (Pubitemid 28053505)
5. Knopp MV, Schoenberg SO, Rehm C, et al. Assessment of gadobenate dimeglumine (gadobenate dimeglumine) for MR angiography: phase I studies. Invest Radiol. 2002;37:706-715. (Pubitemid 35429192)
6. Kroencke TJ, Wasser MN, Pattynama PMT, et al. Gadobenate dimeglumine-enhanced magnetic resonance angiography of the abdominal aorta and renal arteries. Am J Roentgenol. 2002;179:1573-1582. (Pubitemid 35386663)
7. Wikström J, Wasser MN, Pattynama PMT, et al. Gadobenate dimeglumine-enhanced magnetic resonance angiography of the pelvic arteries. Invest Radiol. 2003;38:504-515. (Pubitemid 36875547)
8. Knopp MV, Giesel FL, von Tengg-Kobligk H, et al. Contrast-enhanced MR angiography of the run-off vasculature: intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglumine. J Magn Reson Imaging. 2003;17:694-702. (Pubitemid 36665874)
9. Völk M, Strotzer M, Lenhart M, et al. Renal time-resolved MR angiography: quantitative comparison of gadobenate dimeglumine and gadopentetate dimeglumine with different doses. Radiology. 2001;220:484-488. (Pubitemid 32667190)
10. Wyttenbach R, Gianella S, Alerci M, et al. Prospective blinded evaluation of Gd-DOTA-versus gadobenate dimeglumine-enhanced peripheral MR angiography, as compared with digital subtraction angiography. Radiology. 2003;227:261-269. (Pubitemid 36384208)
11. Prokop M, Schneider G, Vanzulli A, et al. Contrast-enhanced MR angiography of the renal arteries: blinded multicenter crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine. Radiology. 2005; 234:399-408. (Pubitemid 40139908)
12. Schneider G, Ballarati C, Grazioli L, et al. Gadobenate dimeglumine-enhanced MR angiography: diagnostic performance of four doses for detection and grading of carotid, renal, and aorto-iliac stenoses compared to digital subtraction angiography. J Magn Reson Imaging. 2007;26:1020-1032. (Pubitemid 47548164)
13. Thurnher S, Miller S, Schneider G, et al. Diagnostic performance of gadobenate dimeglumine enhanced MR angiography of the iliofemoral and calf arteries: a large-scale multicenter trial. Am J Roentgenol. 2007;189:1223-1237. (Pubitemid 350033021)
14. Soulez G, Pasowicz M, Benea G, et al. Renal artery stenosis evaluation: diagnostic performance of gadobenate dimeglumine-enhanced MR angiography-comparison with DSA. Radiology. 2008;247:273-285.
15. Bueltmann E, Erb G, Kirchin MA, et al. Intra-individual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for contrastenhanced magnetic resonance angiography of the supraaortic vessels at 3 Tesla. Invest Radiol. 2008;43:695-702.
16. Gerretsen SC, le Maire TF, Miller S, et al. Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for MR angiography of peripheral arteries. Radiology. 2010;255:988-1000.
17. Schneider G, Pasowicz M, Vymazal J, et al. Multicenter intraindividual comparison of gadobenate dimeglumine and gadofosveset for contrast-enhanced magnetic resonance angiography of the renal arteries. Am J Roentgenol. 2010;195:476-485.
18. Bluemke DA, Stillman AE, Bis KG, et al. Carotid MR angiography: phase II study of safety and efficacy for gadofosveset. Radiology. 2001;219:114-122. (Pubitemid 32234062)
19. Rapp JH, Wolff SD, Quinn SF, et al. Aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease: safety and efficacy of gadofosveset-enhanced MR angiography-multicenter comparative phase III study. Radiology. 2005;236:71-78. (Pubitemid 40853296)
20. Goyen M, Edelman M, Perreault P, et al. MR angiography of aortoiliac occlusive disease: a phase III study of the safety and effectiveness of the blood-pool contrast agent gadofosveset. Radiology. 2005;236:825-833. (Pubitemid 41170843)
21. McGregor R, Vymazal J, Martinez-Lopez M, et al. A multi-center, comparative, phase 3 study to determine the efficacy of gadofosveset-enhanced magnetic resonance angiography for evaluation of renal artery disease. Eur J Radiol. 2008;65:316-325. (Pubitemid 351179949)
22. Anzidei M, Napoli A, Cavallo Marincola B, et al. Gadofosveset-enhanced MR angiography of carotid arteries: does steady-state imaging improve accuracy of first-pass imaging? Comparison with selective digital subtraction angiography. Radiology. 2009;251:457-466.
23. Cavagna FM, Maggioni F, Castelli PM, et al. Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol. 1997;32:780-796. (Pubitemid 28053510)
24. Giesel FL, von Tengg-Kobligk H, Wilkinson ID, et al. Influence of human serum albumin on longitudinal and transverse relaxation rates (R1 and R2) of magnetic resonance contrast agents. Invest Radiol. 2006;41:222-228. (Pubitemid 44406182)
25. Pintaske J, Martirosian P, Graf H, et al. Relaxivity of gadopentetate dimeglumine (Magnevist), gadobutrol (Gadovist), and gadobenate dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla erratum in Invest Radiol. Invest Radiol. 2006;41:213-221. (Pubitemid 44406181)
26. Rohrer M, Bauer H, Mintorovitch J, et al. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol. 2005;40:715-724. (Pubitemid 41546838)
27. Anzidei M, Napoli A, Cavallo Marincola B, et al. High-resolution steady state magnetic resonance angiography of the carotid arteries: are intravascular agents necessary? Feasibility and preliminary experience with gadobenate dimeglumine. Invest Radiol. 2009;44:784-792.
28. Anzidei M, Napoli A, Zaccagna F, et al. First-pass and high-resolution steady-state magnetic resonance angiography of the peripheral arteries with gadobenate dimeglumine: an assessment of feasibility and diagnostic performance. Invest Radiol. 2011;46:307-316.
29. Yrjänä SK, Vaara T, Karttunen A, et al. Pulse repetition time and contrast enhancement: simulation study of Gd-BOPTA and conventional contrast agent at different field strengths. Invest Radiol. 2008;43:267-275. (Pubitemid 351416770)
30. Bleicher AG, Kanal E. A serial dilution study of gadolinium-based MR imaging contrast agents. Am J Neuroradiol. 2008;29:668-673. (Pubitemid 351571544)
31. Spinazzi A, Lorusso V, Pirovano G, et al. Safety, tolerance, biodistribution and MR imaging enhancement of the liver with gadobenate dimeglumine. Acad Radiol. 1999;6:282-291.
32. Anzalone N, Scomazzoni F, Castellano R, et al. Carotid artery stenosis: intra-individual correlations of unenhanced 3D time-of-flight MR angiography, contrast-enhanced MR angiography, conventional DSA, and rotational angiography for detection and grading. Radiology. 2005;236:204-213. (Pubitemid 40853314)
33. Anzalone N, Scomazzoni F, Cirillo M, et al. Follow-up of coiled cerebral aneurysms: comparison of three-dimensional time-of-flight magnetic resonance angiography at 3 Tesla with three-dimensional time-of-flight magnetic resonance angiography and contrast-enhanced magnetic resonance angiography at 1. 5 Tesla. Invest Radiol. 2008;43:559-567.
34. Haacke EM, Brown RW, Thompson MR, et al. Magnetic Resonance Imaging-Physical Principles and Sequence Design. New York, PA: A John Wiley & Sons, Inc; 1999.
35. Niendorf ER, Santyr GE, Grist TM. Measurement of Gd-DTPA dialysis clearance rates by using a lock-locker imaging technique. Magn Reson Med. 1996;36:571-578. (Pubitemid 26330878)
36. Zheng J, Venkatesan R, Haacke EM, et al. Accuracy of T1 Measurements at high temporal resolution: feasibility of dynamic measurement of blood T1 after contrast administration. J Magn Reson Imaging. 1999;10:576-581. (Pubitemid 29468262)
37. Zhou R, Pickup S, Yankeelov TE, et al. Simultaneous measurement of arterial input function and tumor pharmacokinetics in mice by dynamic contrast enhanced Imaging: effect of transcytolemmal water exchange. Magn Reson Med. 2004;52:248-257. (Pubitemid 39025268)
38. Bock M, Schulz J, Ueltzhoeffer S, et al. Intravascular contrast agent T1 shortening: fast T1 relaxometry in a carotid volunteer study. Magn Reson Mater Phy. 2008;21:363-368.
39. Wang MS, Haynor DR, Wilson GJ, et al. Maximizing contrast-to-noise ratio in ultra-high resolution peripheral MR angiography using a blood pool agent and parallel imaging. J Magn Reson Imag. 2007;26:580-588. (Pubitemid 350194579)
40. Hartmann M, Wiethoff AJ, Hentrich HR, et al. Initial imaging recommendations for Vasovist angiography. Eur Radiol. 2006;16(suppl 2):B15-B23.
41. Bonel HM, Saar B, Hoppe H, et al. MR angiography of infrapopliteal arteries in patients with peripheral arterial occlusive disease by using gadofosveset at 3.0 T: diagnostic accuracy compared with selective DSA. Radiology. 2009; 253:879-890.